Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A 2021 study in published in NEJM of obese adults that used once-weekly injections found weight loss by 10% or more
Contact your healthcare provider, pharmacy, or the manufacturer for guidance
GLP-1 medications such as semaglutide work by influencing appetite signaling and slowing gastric emptying
Although most of the current evidence is derived from preclinical studies, these findings provide important insights that may inform future clinical research on diabetes-related male reproductive dysfunction
To all these problems, innovation is, and will likely stay, the answer
Semaglutide May Be Best For: Individuals who want a well-studied, FDA-approved medication with extensive long-term safety data Patients who prioritize cardiovascular risk reduction (supported by the SELECT trial) People seeking a medication with established insurance coverage pathways Individuals with moderate weight loss goals (10-15% of body weight) Patients who value the reassurance of a medication used by millions of people worldwide Retatrutide May Be Best For (Once Available): Individuals who need greater than 15-20% body weight loss Patients who have plateaued on semaglutide or tirzepatide People with significant metabolic dysfunction who may benefit from the glucagon receptors effects on liver fat and energy expenditure Individuals with MASH (metabolic dysfunction-associated steatohepatitis) given the glucagon receptors role in hepatic fat metabolism Patients willing to use a newer medication with less long-term safety data in exchange for potentially greater efficacy What to Expect During Treatment Starting Semaglutide Weeks 1-4: Starting dose of 0.25 mg weekly
US$ 27.65
US$ 20.51
US$ 24.55
US$ 23.50
US$ 23.62
US$ 24.10
US$ 20.21
US$ 27.32
US$ 25.52
US$ 27.21
US$ 29.94
